In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

Recognizing the value of the discovery and validation of new pharmaceutical targets would be a major step forward for pharmaceutical policy. Patent law has a significant influence on drug ...

However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

Since then, it has grown into one of Astellas’ top-selling drugs ... up nearly 10%. The case – heard in a Delaware district court – was focused on US Patent No. 10,842,780 covering extended ...

While the US is a $600 billion pharmaceutical market, the share of these generic is 90 per cent in terms of volume but a low ...

Alpha Cognition Inc. (NASDAQ: ACOG) ("Alpha Cognition" (ACI), or the "Company"), a biopharmaceutical company developing novel ...

The patent application No. 17/309,952 entitled “An A3 adenosine receptor ligand for use for achieving a fat loss effect”, has been accepted by the US Patent Office, will be issued on February ...

With $2.5 billion annual sales in 2014, Gilenya is the highest revenue generating drug for Novartis worldwide and contributes significant value to its IP portfolio. However, the US Patent and ...

The patent covers the oral administration of the drug to treat obesity. Credit: Cynthia A Jackson/Shutterstock. Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for ...

The success of Epidiolex prompted several companies to attempt to create generic versions. Jazz Pharmaceuticals plc (NASDAQ: ...